Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

11.38
Delayed Data
As of Aug 26
 +0.17 / +1.52%
Today’s Change
6.36
Today|||52-Week Range
16.62
+7.97%
Year-to-Date
No recent news for Innoviva Inc.

Today’s Trading

Previous close11.21
Today’s open11.21
Day’s range11.07 - 11.41
Volume590,109
Average volume (3 months)663,442
Market cap$1.3B
Dividend yield8.79%
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+89.33%
Earnings growth (this year)+476.25%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+247.57%
P/E ratio66.9
Price/Sales17.94
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LCILannett Company Inc-0.60-1.72%
SRPTSarepta Therapeutics...+1.02+3.96%
SAGESAGE Therapeutics In...+1.16+3.10%
DEPODepomed Inc-0.07-0.35%
Data as of 4:01pm ET, 08/26/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$0.19
Annual revenue (last year)$67.8M
Annual profit (last year)-$18.8M
Net profit margin-27.68%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs